Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Wacker and Biosyntia to make biobased biotin in Europe

by Matt Blois
January 13, 2022 | A version of this story appeared in Volume 100, Issue 2

 

Small-scale fermenters.
Credit: Biosyntia
Biosyntia is already producing fermentation-based biotin in the lab.

Hoping to capitalize on growing interest in wellness, Germany’s Wacker Chemie is teaming up with the Danish biotech firm Biosyntia to produce biotin, also called vitamin B7, at a site in Europe using a fermentation process. Biotin is usually made synthetically. China is a major biotin producer, accounting for more than 90% of the biotin imported to the US. Wacker already has a Spanish fermentation plant that makes the amino acid cysteine, another fine chemical produced in large quantities in China.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.